Interaction between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Recent Negative Stressor in Harm Avoidance

被引:26
|
作者
Kim, Seog Ju [3 ]
Cho, Seong-Jin [3 ]
Jang, Ha Min [3 ]
Shin, Jonghan [4 ,6 ]
Park, Pil-Whan [5 ]
Lee, Yu Jin [3 ]
Cho, In Hee [3 ]
Choi, Jung-Eun [1 ,2 ]
Lee, Heon-Jeong [1 ,2 ]
机构
[1] Korea Univ, Coll Med, Dept Psychiat, Seoul 135760, South Korea
[2] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 135760, South Korea
[3] Gachon Univ Med & Sci, Dept Psychiat, Inchon, South Korea
[4] Gachon Univ Med & Sci, Neurosci Res Inst, Inchon, South Korea
[5] Gachon Univ Med & Sci, Dept Lab Med, Inchon, South Korea
[6] Korea Univ, Coll Med, Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 135760, South Korea
关键词
Brain-derived neurotrophic factor; Stressor; Harm avoidance; OBSESSIVE-COMPULSIVE DISORDER; FACTOR GENETIC-POLYMORPHISM; FACTOR BDNF GENE; PERSONALITY-TRAITS; SUICIDAL-BEHAVIOR; BIPOLAR DISORDER; MOOD DISORDERS; CODING VARIANT; HUMAN-MEMORY; LIFE EVENTS;
D O I
10.1159/000258639
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There have been controversial results regarding the association between brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and anxiety-related traits such as harm avoidance (HA). We aimed to investigate the interaction between BDNF Val66Met polymorphism and negative life stressors in HA. BDNF Val66Met polymorphism was genotyped in 391 community-dwelling Koreans (152 males, 239 females; 43.2 +/- 14.1 years old). The Temperament and Character Inventory (TCI) and the Center for Epidemiological Studies for Depression Scale (CES-D) were self applied. The Structured Clinical Interview for DSM-IV axis I disorders and face-to-face interviews investigating negative life stressors within the last 6 months were also performed. There was no significant difference in TCI score, major depressive disorder prevalence and CES-D score among the 3 genotypes (94 Met/Met, 188 Val/Met and 109 Val/Val subjects). There was no significant difference in TCI scores between subjects with stressors and those without stressors, while more common major depressive episodes (p = 0.03) and higher CES-D scores (p < 0.001) were found in subjects with stressors. However, there was a significant interaction between the BDNF genotype and negative life stressors in HA (p = 0.02). Only subjects with the Val/Val genotype showed higher HA with recent negative stressors. Our finding suggests that BDNF Val66Met polymorphism might influence HA by interacting with recent negative stress experience. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:19 / 26
页数:8
相关论文
共 50 条
  • [31] Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients
    Sarchiapone, Marco
    Carli, Vladimir
    Roy, Alec
    Iacoviello, Licia
    Cuomo, Chiara
    Latella, Maria Carmela
    di Giannantonio, Massimo
    Janiri, Luigi
    de Gaetano, Monica
    Janal, Malvin N.
    NEUROPSYCHOBIOLOGY, 2008, 57 (03) : 139 - 145
  • [32] The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease
    Chuu, Jenny Y-J
    Taylor, Joy L.
    Tinklenberg, Jared
    Noda, An
    Yesavage, Jerome
    Murphy, Greer M., Jr.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (01) : 43 - 49
  • [33] Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder
    Wang, Jun
    Zhang, Fuquan
    Zhu, Wenxian
    Liu, Yansong
    Zhou, Zhenhe
    ACTA NEUROPSYCHIATRICA, 2015, 27 (06): : 327 - 335
  • [34] The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression
    Hwang, Jen-Ping
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Yang, Chen-Hong
    Lirng, Jiing-Feng
    Yang, Ya-Min
    NEUROBIOLOGY OF AGING, 2006, 27 (12) : 1834 - 1837
  • [35] The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse
    Stronska-Pluta, Aleksandra
    Suchanecka, Aleksandra
    Chmielowiec, Krzysztof
    Chmielowiec, Jolanta
    Boron, Agnieszka
    Masiak, Jolanta
    Sipak-Szmigiel, Olimpia
    Reclaw, Remigiusz
    Grzywacz, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [36] Association between brain-derived neurotrophic factor val66met gene polymorphism and progressive brain volume changes in schizophrenia
    Ho, Beng-Choon
    Andreasen, Nancy C.
    Dawson, Jeffrey D.
    Wassink, Thomas H.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (12) : 1890 - 1899
  • [37] Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder
    Lam, P
    Cheng, CY
    Hong, CJ
    Tsai, SJ
    NEUROPSYCHOBIOLOGY, 2004, 49 (04) : 178 - 181
  • [38] No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients
    Kang, Seung-Gul
    Choi, Jung-Eun
    An, Hyonggin
    Lim, Se-Won
    Lee, Heon-Jeong
    Han, Changsu
    Kim, Yong-Ku
    Kim, Seung-Hyun
    Cho, Sung Nam
    Lee, Min-Soo
    Joe, Sook-Haeng
    Jung, In-Kwa
    Kim, Leen
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06) : 1545 - 1548
  • [39] Association Between Val66Met Brain-Derived Neurotrophic Factor (BDNF) Gene Polymorphism and Post-Treatment Relapse in Alcohol Dependence
    Wojnar, Marcin
    Brower, Kirk J.
    Strobbe, Stephen
    Ilgen, Mark
    Matsumoto, Halina
    Nowosad, Izabela
    Sliwerska, Elzbieta
    Burmeister, Margit
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (04) : 693 - 702
  • [40] Gene-environment interaction between the brain-derived neurotrophic factor Val66Met polymorphism, psychosocial stress and dietary intake in early psychosis
    Gattere, Giulia
    Stojanovic-Perez, Alexander
    Monseny, Rosa
    Martorell, Lourdes
    Ortega, Laura
    Montalvo, Itziar
    Sole, Montse
    Jose Algora, Maria
    Cabezas, Angel
    Reynolds, Rebecca M.
    Vilella, Elisabet
    Labad, Javier
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 (05) : 811 - 820